2013-14至2015-16年度流感疫苗有效性:儿童中的检测阴性研究
该检测阴性研究纳入2013-16年1-17岁儿童6779例,比较流感阳性与阴性病例的疫苗接种状态以估计疫苗有效性(VE)。三价灭活疫苗(IIV3)与四价灭活疫苗(IIV4)VE相近(60%、57%、53%),四价减毒活疫苗(LAIV4)对甲型流感效果较差但对乙型流感较好,尤其5-17岁儿童VE=100%(95%CI: 55, 100)。
要点
- IIV3与IIV4在三季VE分别为60%、57%、53%,换用IIV4未影响VE。
- LAIV4对甲型流感VE为15%、37%、48%,对乙型为100%、56%、100%。
- 5-17岁儿童中LAIV4对乙型流感VE=100%(95%CI: 55, 100)。
核心结论
- 流感疫苗接种在各年度显示适度但一致的有效性。
- IIV3换为IIV4未影响VE。
- LAIV4表现不如灭活疫苗,但逐年改善,对较大儿童乙型流感保护尤其好。
- 结果强调流感的地区性及本地监测的必要性。
研究设计与样本
- 检测阴性设计,纳入2013-16年1-17岁因呼吸道疾病就诊并检测流感的儿童6779例。
- 接种定义:检测前≥10天接种≥1剂流感疫苗。
- 年龄分组为1-4岁和5-17岁。
- 通过比较流感阳性与阴性病例的接种状态估计VE。
主要发现
- 总接种率27.2%(87.1%为IIV3或IIV4,12.9%为LAIV4),流感阳性率15.6%(77.9%为甲型)。
- IIV3与IIV4三季VE分别为60%、57%、53%,对甲型和乙型及两个年龄组表现相似。
- LAIV4对甲型流感VE为15%、37%、48%,对乙型流感VE为100%、56%、100%。
- 5-17岁儿童中LAIV4对乙型流感VE=100%(95%CI: 55, 100)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Trivalent inactivated and live attenuated influenza vaccines (IIV3 and LAIV3) have been reformulated with an extra B strain (IIV4 and LAIV4). They were licensed based on immunogenicity and their effectiveness (VE) still must be empirically tested. METHODS: Children 1-17years tested for influenza during 2013-16 were included and their immunization status verified. They were considered vaccinated if received ≥1 dose of an influenza vaccine ≥10days before evaluated for a respiratory episode. Age-groups were classified as 1-4years or 5-17years. VE was estimated by comparing vaccination status of influenza-positive versus influenza-negative cases. RESULTS: 6779 children were enrolled in the three seasons. Overall, 27.2% received an influenza vaccine (87.1% IIV3 or IIV4 and 12.9% LAIV4), and 15.6% tested positive for influenza (77.9% A). IIV3 was predominantly used in 2013-14 and IIV4 in 2014-15 and 2015-16. IIV3 and IIV4 had comparable VE over the three seasons (60%, 57% and 53%) and performed similarly against influenza A and B and both age-groups. LAIV4 performed poorly for influenza A (15%, 37% and 48%) but better for influenza B (100%, 56% and 100%), especially among children 5-17years of age with VE=100% (95%CI: 55, 100). CONCLUSIONS: Influenza vaccination showed modest but consistent effectiveness over the years. The switch from IIV3 to IIV4 did not affect VE. LAIV4 did not perform as well as IIVs, yet it improved over the years and was particularly good protecting older children against influenza B. These results emphasize the regional nature of influenza and the need for local surveillance.
引用
- Valdin HL, Bégué RE. Influenza vaccines effectiveness 2013-14 through 2015-16, a test-negative study in children. Vaccine. 2017. PMID: 28669621. doi:10.1016/j.vaccine.2017.06.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。